CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...
Phase 3
Taipei, Taiwan and 46 other locations
To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...
Taipei City, Taiwan and 89 other locations
with vehicle control in subjects with Wagner Grade 1 to Grade 2 diabetic foot ulcers. Baseline target ulcer size (\<16 cm2 vs ≥16 cm2 ) will...
Phase 3
Taipei, Taiwan and 20 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Taipei, Taiwan and 652 other locations
This study compares 2 medicines for type 2 diabetes: semaglutide (new medicine) and a dummy medicine (placebo). Semaglutide will be tested t...
Phase 3
Taipei, Taiwan and 72 other locations
in improving blood sugar control in participants with type 2 diabetes (T2D) with inadequate glycemic control using metformin. The study will...
Phase 3
Taipei, Taiwan and 77 other locations
double-blinded, vehicle-controlled, parallel, phase II study to evaluate the efficacy and safety of topical BB-101 for the treatment of diabetic...
Phase 2
Taipei, Taiwan
at Week 52 in participants with overweight or obesity without diabetes mellitus (Cohort A) and in participants with overweight or obesity wi...
Phase 2
Taipei, Taiwan and 78 other locations
This study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new inv...
Phase 3
Taipei, Taiwan and 185 other locations
This study will look at how much CagriSema lowers blood sugar and body weight in people with type 2 diabetes. CagriSema is a new investigati...
Phase 3
Taipei, Taiwan and 160 other locations
Clinical trials
Research sites
Resources
Legal